Skandinaviska Enskilda Banken AB (Publ) / ELV
Skandinaviska Enskilda Banken AB (Publ)’s Elevance Health Inc Formerly Position
Does Skandinaviska Enskilda Banken AB (Publ) own Elevance Health Inc Formerly (ELV)? Not currently — the last reported position was 45.7K shares worth $16M in Q4 2025; the fund’s latest 13F (Q1 2026) no longer reports it.
Position Value
$16M
Q4 2025
Shares
45.7K
% of Portfolio
+0.06%
Quarters Held
29
position exited
Position History ELV
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q4 2025 | 45.7K | $16M | +0.06% |
| Q3 2025 | 47.4K | $15M | +0.06% |
| Q2 2025 | 62.5K | $24M | +0.11% |
| Q1 2025 | 50.4K | $22M | +0.11% |
| Q4 2024 | 63.8K | $24M | +0.11% |
| Q3 2024 | 77.2K | $40M | +0.19% |
| Q2 2024 | 104.9K | $57M | +0.27% |
| Q1 2024 | 170.8K | $89M | +0.43% |
| Q4 2023 | 187.2K | $88M | +0.51% |
| Q3 2023 | 192.0K | $83,618 | +0.55% |
| Q2 2023 | 195.0K | $86,656 | +0.57% |
| Q1 2023 | 184.4K | $84,806 | +0.59% |
| Q4 2022 | 160.1K | $82,138 | +0.62% |
| Q3 2022 | 143.6K | $65M | +0.50% |
| Q2 2022 | 194.9K | $94M | +0.69% |
| Q1 2022 | 154.0K | $76M | +0.44% |
| Q4 2021 | 130.2K | $61M | +0.31% |
| Q3 2021 | 136.1K | $51M | +0.28% |
| Q2 2021 | 108.5K | $41M | +0.25% |
| Q1 2021 | 88.4K | $32M | +0.21% |
| Q4 2020 | 62.1K | $20M | +0.14% |
| Q3 2020 | 54.4K | $15M | +0.11% |
| Q2 2020 | 46.4K | $12M | +0.10% |
| Q1 2020 | 47.9K | $11M | +0.12% |
| Q4 2019 | 54.5K | $16M | +0.13% |
| Q3 2019 | 54.4K | $13M | +0.11% |
| Q2 2019 | 49.2K | $14M | +0.12% |
| Q1 2019 | 41.9K | $12M | +0.11% |
| Q4 2018 | 40.6K | $11M | +0.10% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Skandinaviska Enskilda Banken AB (Publ)’s full portfolio or all institutional holders of ELV.